- Q’Apel Medical, Inc., a Fremont, Calif.-based neurovascular company, raised $22M in Series C funding
- The round included River Cities Capital, Soleus Capital, and incumbent investor Research Corporation Technologies (RCT)
- Scott Huennekens, former Chairman, CEO and President of Verb Surgical, and Carter McNabb, Managing Director, River Cities Capital, will join the Board of Directors
- Walrus BGC specifically designed to assist doctors in performing mechanical thrombectomy procedures on stroke patients
- The Wahoo Control™ Catheter a dual-mode hybrid access system, providing two distinct operational modes – Tracking Mode and Support Mode
- In 2021, Q’Apel plans to significantly increase its manufacturing capacity, add additional head count and expand their product portfolio
